Learn More
Description
The M18/2 antibody reacts with the common β 2 chain of LFA-1 (CD11a/CD18, α L β 2 integrin), Mac-1 (CD11b/CD18, α M β 2 integrin), and gp150, 95 (CD11c/CD18, α X β in vivo metastasis of the LB lymphoma to the spleen and that it blocks in vitro formation of aggregates of LB cells and splenocytes. However, other reports indicate that mAb M18/2 has no effect on CTLmediated killing, adherence of C3bi-sensitized erythrocytes to Mac-1, antigen-specific binding of T cells to antigen-producing cells, or rejection of cardiac allografts. Recent in vitro studies indicate that M18/2 antibody stimulates adhesion of Mac-1 to its ligands C3bi and ICAM-1, and it stimulates adhesion of LFA-1 to ICAM-1, but it has no effect upon the interactions of LFA-1 with ICAM-2 nor ICAM-3.
Specifications
Specifications
| Antigen | CD18 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | M18/2 |
| Concentration | 0.5mg/mL |
| Conjugate | Unconjugated |
| Description | Integrin β2 chain |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Host Species | Rat |
| Immunogen | Mouse CTL glycoproteins |
| Show More |
For Research Use Only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.